4-甲酰氨基安替比林
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide;N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide;(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide;4-Formylamino Antipyrine;Formamide,N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-;N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)formamide;1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylformamide;4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one;4-formyl-aminoanti;4-Formylaminoantipyrine (N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide;Formamide,N-antipyrinyl;N-(2,3-dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)carboxamide;4-Carboxamido-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazole-3-one;4-Carboxamido-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one;N-(2,3-dihy-dro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide;carboxamidoantipyrine;NSC 60565;4-ForMaMidoantipyrine;4-Formylaminoantipyrin;N-AntipyrinylforMaMide;Formamide, N-antipyrinyl-;WLN: T5NNVJ A1 BR& DMVH E1;4-ForMylaMinoantipyrine FAA;MetaMizole IMpurity A (4-ForMylaMino Antipyrine);N-(1,5-Dimethyl-3-oxo-2-;4-Formylaminoantipyrine;63DKU1M0XK;4-Formylaminophenazone;N-(2,3-dimethyl-5-oxo-1-phenyl-3-py;MFCD00085457;N-Antipyrinylformamide;FT-0648425;HMS1673G16;Oprea1_056999;1672-58-8;DTXSID10168241;J61.595A;C73223;Formamide,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-;NSC-60565;AG-690/12869770;Oprea1_347608;4-Formamidoantipyrine;UNII-63DKU1M0XK;DS-15213;EINECS 216-808-3;Metamizole Impurity A;4-Formylaminoantipyrine, VETRANAL(TM), analytical standard;4-Formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one (4-Formylaminophenazone);NS00000329;N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide;AKOS000633307;4-FAA;HY-133588;N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4- yl)formamide;CS-0128286;4-(FORMYLAMINO)-1-PHENYL-2,3-DIMETHYL-1H-PYRAZOLE-5(2H)-ONE;4-(Formylamino)antipyrine;W-109692;Metamizole impurity A, European Pharmacopoeia (EP) Reference Standard;4-Formylaminoantipyrine 100 microg/mL in Acetonitrile;Formamide, N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-;WSJBSKRPKADYRQ-UHFFFAOYSA-N;4formylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one;N-antipyrinyl formamide;Q27156916;METAMIZOLE SODIUM MONOHYDRATE IMPURITY A [EP IMPURITY];(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide;CHEBI:83526;NSC60565;F1289;N-(2,3-2H-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide;SCHEMBL6812409;N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)formamide